Cannabis News

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") is pleased to announce it has engaged Pure Product Brokers for sales representation for Better Plant's Urban Juve products, commencing immediately.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/72806_b5ea59a054310a89_001.jpg

Better Plant Appoints Pure Product Brokers for Sales in U.S., Australia and Japan

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6377/72806_b5ea59a054310a89_001full.jpg

Urban Juve is a plant-based skincare line based on Ayurveda and holistic healing principles. Urban Juve has a complete line of face serum, face moisturizers, face mists, body oils, and a lip balm that are crafted with plant-based ingredients.

Pure Product Brokers Founder and President, Maureen Malloy, is trained as a Registered Nurse in the state of California and has 25 years of experience in the Beauty and Wellness industry growing multiple brands into retail successes at a national level. "I always look at a brand in terms of balance of innovation and familiarity, whether it's in formulation, packaging or marketing style," says Ms. Malloy. "Urban Juve is right on time with this super-intelligent skincare system. No one has done Ayurvedic formulation to this level of quality before."

Pure Product Brokers represent a wide range of carefully chosen brand partners in the natural skincare space and has successfully launched brands at a national level with such retailers as Sephora and Nordstrom.

"In addition to sharing our company values, Maureen and her team have a proven track record of success and are well-respected for their work in the beauty industry," says Amber Allen, Director of Sales for Better Plant. "I look forward to uniting our efforts to bring Urban Juve to new markets and diversifying our distribution channels to reach more customers."

As sales representatives, Pure Product Brokers will solicit orders for Urban Juve products in the US, Australia, Japan, and any additional regions mutually agreed to by both parties. Under the agreement Pure Products will engage in the sales and promotion of products to develop initiate and increase volume of business for Urban Juve, provide continual education to regional and headquarter buyers and retail sales teams, coordinate launch and seasonal education events and educational support for retail sales teams, and consult Urban Juve on best practices required to create a successful product launch within the targeted channels of business and within specific key account formats.

About Better Plant Sciences Inc.

Better Plant offers plant-based products for optimum health and wellness. It is a vertically integrated company with a team whose complementary experience enables acquisition, development, manufacturing, and direct-to-consumer distribution of its products. Its all-natural products vary in use from pain treatment to disease prevention to skin care, all without chemicals or harmful ingredients. It has an extensive catalogue of over 400 proprietary product formulas. Better Plant currently has over 70 plant-based products for sale through eCommerce and/or in retail stores under the brands Jusu, Urban Juve, and Wright & Well. Better Plant also owns approximately 29% of NeonMind Biosciences Inc.

For more information on Better Plant, visit betterplantsciences.com or follow @betterplantsciences on Instagram. Buy Urban Juve products at urbanjuve.com or follow @urbanjuve on Instagram.

Penny White, President & CEO
penny@betterplantsciences.com
1-833-514-2677

Investor Relations:

Alexandra Dumanski
invest@betterplantsciences.com
1-833-514-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, "forward looking statements") under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies due to the spread of COVID-19, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company's products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Better Plant cautions readers not to place undue reliance on forward-looking statements provided by Better Plant, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Better Plant expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/72806

News Provided by Newsfile via QuoteMedia

Curaleaf Launches Plant Precision, New Product Line Targeting Specific Health and Wellness Categories

Plant Precision fills consumer demand for low dose THC formats that are geared towards everyday wellness as 75% of Americans would consider using cannabis for health and wellness purposes*

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the launch of Plant Precision, a curated collection of edibles and a topical gel designed to target specific wellness categories.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
closeup of congress building on dollar bill

Cannabis Weekly Round-Up: New US Cannabis Bill Arrives, Path Forward Uncertain

A new piece of legislation geared at federal cannabis reform was introduced in the US Senate this week. However, experts aren’t confident that it will be approved by Congress.

Investors also saw a top analyst change their perspective on some cannabis companies in Canada.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

TerrAscend to Delight NJ Shoppers with an Immersive Cookies Experience

New Jersey's First-Ever Cookies Corner Opening Tomorrow at The Apothecarium Maplewood

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced with Cookies, a globally recognized cannabis and lifestyle brand, the opening of New Jersey's first-ever "Cookies Corner" at The Apothecarium location in Maplewood . Additional Cookies Corners are scheduled to launch in Lodi and Phillipsburg in the near future. All three retail spaces will offer exclusive Cookies products and accessories through an immersive, branded shopping experience.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Canopy Growth to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the first quarter fiscal year 2023 ended June 30, 2022 before financial markets open on August 5, 2022 .

Canopy Growth to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022 (CNW Group/Canopy Growth Corporation)

Following the release of its first quarter fiscal year 2023 financial results, Canopy Growth will host an audio webcast with David Klein , CEO and Judy Hong , CFO on August 5, 2022 , at 10:00 AM ET .

Management will address questions during a Q&A portion of the call related to Canopy Growth's business and financial results. Additionally, verified shareholders can submit and upvote questions in advance using a platform developed by Say Technologies. Shareholders can submit questions starting on July 29, 2022, at 10:00 am ET by visiting:

https://app.saytechnologies.com/canopy-growth-corporation-2023-q1 .

The platform will close on August 4, 2022 , at 10:00 am ET .

Webcast Information

A live audio webcast will be available at:

https://app.webinar.net/bXk1q7d6DRl

Replay Information

A replay will be accessible by webcast until 11:59 PM ET on November 5, 2022 at:

https://app.webinar.net/bXk1q7d6DRl

About Canopy Growth Corporation

Canopy Growth (TSX: WEED , NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany . Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada , the United States , and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit www.canopygrowth.com .

Notice Regarding Forward Looking Statements

This press release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as "intend," "goal," "strategy," "estimate," "expect," "project," "projections," "forecasts," "plans," "seeks," "anticipates," "potential," "proposed," "will," "should," "could," "would," "may," "likely," "designed to," "foreseeable future," "believe," "scheduled" and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward‐looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward‐looking statements and the forward‐looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation ("Canopy") can be found under the section entitled "Risk Factors" in Canopy's Annual Report on Form 10-K for the year ended March 31, 2022 , filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com , respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward‐looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward‐ looking statement. Readers are cautioned not to put undue reliance on any forward‐looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/canopy-growth-to-report-first-quarter-fiscal-2023-financial-results-on-august-5-2022-301591572.html

SOURCE Canopy Growth Corporation

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2022/22/c1953.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
cannabis plant

Canadian Producers, US States to Watch and M&A — Experts Review Cannabis in H1 2022

What do experts and executives involved in the cannabis market think of the developments seen in 2022?

At the halfway mark of the year, investments in cannabis are down, a path to federal reform in the US remains murky and the Canadian leaders of old are still bleeding cash.

Here the Investing News Network (INN) brings investors a closer look at what industry observers are thinking about the general progress for 2022 so far.

Keep reading...Show less

TERRASCEND TO HOST SECOND QUARTER 2022 EARNINGS CONFERENCE CALL

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it will host a scheduled conference call to discuss the results for its second quarter ended June 30, 2022 on Thursday, August 11, 2022 at 5:00 p.m. Eastern Time . The Company will report its financial results for the second quarter the same day after market close.

CONFERENCE CALL DETAILS

The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About TerrAscend

TerrAscend is the leading North American cannabis operator with vertically integrated operations in Pennsylvania , New Jersey , Michigan and California , licensed cultivation and processing operations in Maryland and licensed production in Canada . TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit www.terrascend.com

SOURCE TerrAscend

Cision View original content: http://www.newswire.ca/en/releases/archive/July2022/21/c0218.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×